Effect of 60-days Saccharomyces Boulardii and Superoxide Dismutase Supplementation in Obese Adults
NCT ID: NCT04919850
Last Updated: 2021-06-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2018-01-15
2020-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of SODB® in Metabolic Adaptations in Overweight Women
NCT02667691
Anti-Obesity Effect of Pediococcus Pentosaceus LP28
NCT01685944
Evaluation of the Body Slimming Effect of TCI904
NCT05805488
A Study of SGB-7342 in Subjects With Obesity or Overweight
NCT07324850
Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects
NCT00909766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
A complex of 250 mg of Saccharomyces boulardii and 500 IU SOD to be assumed twice/day for 8 weeks at mealtimes
Saccharomyces boulardii and SOD
A complex of 250 mg of Saccharomyces boulardii and 500 IU SOD to be assumed twice/day for 8 weeks at mealtimes
Placebo group
A placebo consisting of capsules containing the same excipients except the active compounds, and the same coating
Placebo
A placebo consisting of capsules containing the same excipients except the active compounds, and the same coating
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Saccharomyces boulardii and SOD
A complex of 250 mg of Saccharomyces boulardii and 500 IU SOD to be assumed twice/day for 8 weeks at mealtimes
Placebo
A placebo consisting of capsules containing the same excipients except the active compounds, and the same coating
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* diagnosis of major depressive disorder
* current medications for weight loss, for control of cholesterol and triglycerides
* anti-inflammatory treatments
* pregrancy of lactation
* type 1 diabetes mellitus, intestinal inflammatory bowel disease, celiac disease, chronic pancreatitis
* probiotic/prebiotic treatment in the last 4 weeks
* antibiotic use within the last 3 months
30 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda di Servizi alla Persona di Pavia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mariangela Rondanelli
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda di Servizi alla Persona
Pavia, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1209/151217
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.